Juul packs are seen on a shelf at Empire Smoke Shop on December 7, 2022 in the Flatbush neighborhood of the Brooklyn borough of New York City.
Miguel M. Santiago | fake images
The Food and Drug Administration announced Thursday that it has reversed its ban on Juul e-cigarettes while it reviews new court decisions and considers updated information provided by the e-cigarette maker.
The FDA first blocked the company from marketing its products in 2022, but they remained on shelves pending an appeal. Juul has maintained its status as the second largest e-cigarette manufacturer in the US during this time.
Now, the FDA says Juul products are again under agency review, although it stressed that this new status was not an indication that they would be fully approved.
He said federal statutes prohibited him from disclosing additional information.
In a statement, Juul said it appreciated the FDA's decision, adding that it now looks forward to “reengaging with the agency in a science- and evidence-based process to obtain marketing authorization” for its products.
“We remain confident in the quality and substance of our applications and believe that a full review of the science and evidence will demonstrate that our products meet the legal standard of being appropriate for the protection of public health,” the company said.
Even as Juul pursued its appeal of the 2022 marketing ban, that initial FDA ruling significantly disrupted the company's finances, prompting a bailout from two of its largest investors, The Wall Street Journal reported.
Juul also continues to face lawsuits from consumers who say its products harm their health. The company has denied those accusations.
To date, the FDA has granted official consumer marketing approval to only 23 e-cigarette products, manufactured by just three companies.
